Harvard Apparatus Ltd.

John F. Kennedy has served as a Director of the Company since October 2000 and currently serves as Chairman of the Audit Committee and is a member of the Compensation Committee. Since June 2006, Mr. Kennedy has served as President and Chief Financial Officer of Nova Ventures Corporation, the management company providing executive management services to the operating companies of Nova Holdings LLC, Nova Analytics Corporation and Nova Technologies Corporation. From July 2002 to June 2006, Mr. Kennedy served as the President and Chief Financial Officer of Nova Analytics Corporation, a worldwide supplier and integrator of analytical instruments. From August 1999 to April 2002, Mr. Kennedy served as the Senior Vice President, Finance, Chief Financial Officer and Treasurer of RSA Security Inc., an e-business security company. Prior to joining RSA Security, Mr. Kennedy was Chief Financial Officer of Decalog, NV, a developer of enterprise investment management software, from 1998 to 1999. From 1993 to 1998, Mr. Kennedy served as Vice President of Finance, Chief Financial Officer and Treasurer of Natural MicroSystems Corporation, a telecommunications company. Mr. Kennedy holds an M.S.B.A. in Accounting from the University of Massachusetts Amherst.

Array

Harvard(1) Bioscience was founded in 1901. Frustrated by the poor quality of equipment then available, Dr. William T. Porter began manufacturing his own high quality physiology teaching equipment in the basement of the Harvard Medical School. Dr. Porter went on to found the American Journal of Physiology and became one of the leading physiologists of his day. His equipment gained an enviable reputation for quality and reliability and began to be known simply as the Harvard Apparatus. The name stuck. In the early 1980's the company started using the name Harvard Bioscience and in 2000 we officially changed the name of the company to Harvard Bioscience, Inc. In 1996 the current management team took over the company and expanded the product offering and improved growth and profitability. We completed our initial public offering in December 2000. Both we and physiology have come a long way in 100 years. Today we are a leading worldwide supplier of scientific instruments used in drug discovery applications. Our products are used across a broad spectrum of both well established and cutting edge applications and are used by the world?s top pharmaceutical and biotech companies.

Mr. Uveges joined the Company's Board of Directors in 2004. He is the Founder and Principal of the Tallwood Group. Prior positions include Past President/Chief Executive Officer of TranXenoGen, Chief Operating Officer of BioSource International, Senior Vice President/Chief Financial Officer of NEN Life Science and Chief Financial Officer/Vice President of Gelman Life Sciences. Mr. Uveges is also a member of the Board of Directors of Harvard Biosciences, Inc. Mr. Uveges serves as Chairman of MFIC's Nominating and Corporate Governance Committee.

Bob Dishman is a scientist with a long history as a successful biotech operating executive and entrepreneur. In the course of his 30+ years of experience, Bob has become recognized as a leading expert in running biotech companies engaged in drug discovery based on bioseparation, purification, and combinatorial chemistry. Bob is perhaps best known as COO of Sepracor, Inc., managing its work in the "pure isomer" form of major pharmaceuticals, and as the founder and CEO of Arqule, Inc., one of the early combinatorial chemistry companies, both of which went public and achieved multimillion dollar valuations. In addition, Bob was the President and Founder of the Milligen Division of Millipore, focused on DNA and peptide synthesizers and sequencers for analysis and synthesis of biological molecules, and CEO of Biotage, Inc., a company he helped re-direct and take public as Dyax Corp. More recently, Bob has been CEO, Chairman or Board member of four other biotech companies both public and private. Dr. Dishman holds a Ph.D. in Analytical Chemistry, a MS in Chemistry, both from the University of Massachusetts, Amherst, and a BS from the University of New Hampshire, Durham.